Cite
Kohlhapp FJ, Broucek JR, Hughes T, et al. NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with interleukin-2 (IL-2) and CTLA-4 blockade. J Immunother Cancer. 2015;3:18doi: 10.1186/s40425-015-0063-3.
Kohlhapp, F. J., Broucek, J. R., Hughes, T., Huelsmann, E. J., Lusciks, J., Zayas, J. P., Dolubizno, H., Fleetwood, V. A., Grin, A., Hill, G. E., Poshepny, J. L., Nabatiyan, A., Ruby, C. E., Snook, J. D., Rudra, J. S., Schenkel, J. M., Masopust, D., Zloza, A., & Kaufman, H. L. (2015). NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with interleukin-2 (IL-2) and CTLA-4 blockade. Journal for immunotherapy of cancer, 318. https://doi.org/10.1186/s40425-015-0063-3
Kohlhapp, Frederick J, et al. "NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with interleukin-2 (IL-2) and CTLA-4 blockade." Journal for immunotherapy of cancer vol. 3 (2015): 18. doi: https://doi.org/10.1186/s40425-015-0063-3
Kohlhapp FJ, Broucek JR, Hughes T, Huelsmann EJ, Lusciks J, Zayas JP, Dolubizno H, Fleetwood VA, Grin A, Hill GE, Poshepny JL, Nabatiyan A, Ruby CE, Snook JD, Rudra JS, Schenkel JM, Masopust D, Zloza A, Kaufman HL. NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with interleukin-2 (IL-2) and CTLA-4 blockade. J Immunother Cancer. 2015 May 19;3:18. doi: 10.1186/s40425-015-0063-3. eCollection 2015. PMID: 25992289; PMCID: PMC4437746.
Copy
Download .nbib